Major Histocompatibility Complex (MHC) Tetramer Technology: An Evaluation
Carolyn M. Constantin(Centers for Disease Control and Prevention), Ora L. Strickland(Emory University), Elizabeth E. Bonney, John D. Altman
Cited by 20
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years–Four states, 2007
|MMWR Morbidity and Mortality Weekly Report|2009|107
Normal Establishment of Virus-Specific Memory CD8 T Cell Pool following Primary Infection during Pregnancy
|The Journal of Immunology|2007|55
Ordering Molecular Genetic Tests and Reporting Results
|Journal of Molecular Diagnostics|2008|37